Dan Levine
Dan Levine
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Special Report: COVID deepens the other opioid crisis - a shortage of hospital painkillers

Special Report: COVID deepens the other opioid crisis - a shortage of hospital painkillers

By , , (Reuters) - As opioid pills and patches fueled a two-decade epidemic of overdoses in the United States, hospitals faced chronic shortages of the same painkillers in injectable form - narcotics vital to patients on breathing machines.For years, hospitals chased supplies, sometimes resorting to inferior substitutes. The shortfall grew so dire in 2018 that a drugmaker sent letters advising hospitals they could use batches of opioid syringes potentially containing hazardous contaminants - so long as they filtered each dose.Then the novel coronavirus struck, and demand for injectable...

June 9, 2020
Share
Save
Review
No Rating
Special Report: Why big business can count on courts to keep its deadly secrets

Special Report: Why big business can count on courts to keep its deadly secrets

By , , NEWARK, New Jersey (Reuters) - In the dreary archives of a Newark, New Jersey, courthouse, Ronald Motley found a treasure map.It was an evidence log, a detailed inventory of documents and other exhibits that had been used in an injured worker’s lawsuit. And it was freely available to anyone who bothered to look for it – for this was long ago in 1978, before the routine use of protective orders, sealed documents and other tools of concealment wrapped U.S. courts in lethal secrecy.Motley, a lanky, deep-drawling South Carolina lawyer, had been representing sick workers in lawsuits...

March 10, 2020
Share
Save
Review
No Rating
Exclusive: Merck anti-baldness drug Propecia has long trail of suicide reports, records show

Exclusive: Merck anti-baldness drug Propecia has long trail of suicide reports, records show

By , (Reuters) - Newly unsealed court documents and other records show that Merck & Co and U.S. regulators knew about reports of suicidal behavior in men taking the company’s anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label.Internal records from Merck were made public in late January, when a federal magistrate in Brooklyn, New York, granted a 2019 Reuters motion to unseal 11 documents filed in years of litigation alleging Propecia caused persistent sexual dysfunction and other harmful side...

February 3, 2021
Share
Save
Review
  • Total 3 items
  • 1
OUTLETS
reuters.com

reuters.com

CRITIC
img-trusted
100%
PUBLIC
img-trusted
80%